And the FDA says tirzepatide is no longer in shortage. Applied Therapeutics said its embattled CEO Shoshana Shendelman resigned and was replaced on an interim basis by current CFO Les Funtleyder.

Orion Corporation (“Orion”) and Abilita Therapeutics (“Abilita”) announced today that they have entered into a research collaboration and option to license agreement to develop innovative antibody ...

Orion Corporation (“Orion”) and Abilita Therapeutics (“Abilita”) announced today that they have entered into a research collaboration and option to license agreement to develop innovative ...

Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics Orion Corporation ("Orion") and Abilita Therapeutics ...

Rogo, the enterprise AI platform trusted by leading financial institutions, today announced it has integrated data from S&P Capital IQ into its AI-powered workflows. This initiative will help ...

"This collaboration combines Abilita's strength in discovering breakthrough antibody therapeutics for challenging membrane protein targets with Orion's proven expertise in oncology, pain, clinical ...